Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

Gachon University

ClinicalTrials.gov lists Gachon University as lead sponsor of 92 trials, counting the companies grouped under it. Gachon University itself has 1 active development program.

KR Academic
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 1 Disease areas Disease areas 116 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 2 Active development programs Active development programs 1 Journals published in Journals published in 129 Organization relationships Organization relationships 65 Latest dated events Latest dated events 130 Biomarkers this organization publishes on Biomarkers this organization publishes on 382 Companies grouped under this page Companies grouped under this page 1 Disease areas Disease areas 116 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 2 Active development programs Active development programs 1 Journals published in Journals published in 129 Organization relationships Organization relationships 65 Latest dated events Latest dated events 130 Biomarkers this organization publishes on Biomarkers this organization publishes on 382

Rows recorded per section (log scale)

16 sections measured, none recorded

This page covers Gachon University and 1 company grouped under it: 92 lead-sponsored trials (2 its own, 90 in the grouped companies) and 2 legal-entity registrations (1 its own, 1 in the grouped companies).

Get the Gachon University report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (1)

Companies grouped under this page
Company Lead trials Legal entities
Gachon University Gil Medical Center 90 1

Disease areas (116)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Insulin Resistance 14
Dyslipidemias 12
Hyperlipidemias 12
Colorectal Neoplasms 10
Coronary Artery Disease 8

Showing 5 of 116 disease areas.

Start your 14-day trial Email me the first 50 disease areas as a PDF

Trials by start year as sponsor or collaborator (2)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials by start year as sponsor or collaborator
Year Trials started
2022 1
2017 1

No forecast is made for this organization: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Active development programs (1)

Active development programs
Drug Disease area Max phase Trials
Treatment As Usual Major Depressive Disorder Not reported 1

Journals published in (129)

Shown in this order: most published in first.

Journals published in
Journal Publications
The New England journal of medicine 8
Gastrointestinal endoscopy 6
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 5
Journal of the American College of Cardiology 5
Annals of oncology : official journal of the European Society for Medical Oncology 4

Showing 5 of 129 journals.

Start your 14-day trial Email me the first 50 journals as a PDF

Organization relationships (65)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Seoul National University Co sponsors trial with 25
Yonsei University Co sponsors trial with 15
Chungnam National University Co sponsors trial with 7
Samsung (South Korea) Co sponsors trial with 7
Asan Foundation Co sponsors trial with 7

Showing 5 of 65 relationships.

Start your 14-day trial Email me the first 50 relationships as a PDF

Latest dated events (130)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-03-18 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-12-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-11-24 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-09-10 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-07-09 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 130 events.

Start your 14-day trial Email me the first 50 events as a PDF

Biomarkers this organization publishes on (382)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
CRP 27
INS 21
EGFR 14
ERBB2 13
ALB 11

Showing 5 of 382 biomarkers.

Start your 14-day trial Email me the first 50 biomarkers as a PDF

Not on this page

Checked, with nothing recorded for this organization: related companies not grouped here, approved assets, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.